Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/70237
ZIKA-RELATED ADVERSE OUTCOMES IN A COHORT OF PREGNANT WOMEN WITH RASH IN PERNAMBUCO, BRAZIL
Congenital Zika syndrome (CZS)
ZIKV infection in pregnancy
Pernambuco, Brazil
Author summary: The ability to meaningfully quantify the absolute and relative risks of Congenital Zika Syndrome is contingent on the accurate identification of ZIKV infections in pregnant women and the long-term follow-up of children at risk. This study builds on the evidence base on ZIKV in pregnancy by not only examining pregnancy and birth outcomes, but also considering later onset manifestations of Congenital Zika Syndrome, conducting a deep and standardized investigation of infant outcomes. In addition, it used unprecedented repeated testing and the use of multiple diagnostic platforms, including qRT-PCR, IgM and IgG3 ELISAs, and PRNTs to identify ZIKV cases. The absolute risk of microcephaly was 2.9%, of calcifications and/or ventriculomegaly was 7.2%, of additional neurologic alterations was 5.3%, of ophthalmologic abnormalities was 7% and of dysphagia was 1.8%. The manifestations presented more frequently in isolation than in combination (i.e., less than 1% of the children experienced abnormalities across all of the domains simultaneously). Although approximately one-fifth of children with confirmed and suspected exposure to ZIKV in pregnancy presented with at least one abnormality compatible with CZS, the manifestations presented more frequently in isolation than in combination.
Author
Ximenes, Ricardo Arraes de Alencar
Miranda-Filho, Demócrito de Barros
Montarroyos, Ulisses Ramos
Martelli, Celina Maria Turchi
Araújo, Thalia Velho Barreto de
Brickley, Elizabeth
Albuquerque, Maria de Fátima Pessoa Militão de
Souza, Wayner Vieira
Ventura, Liana O.
Ventura, Camila V.
Gois, Adriana L.
Leal, Mariana C.
Oliveira, Danielle Maria da Silva
Eickmann, Sophie Helena
Carvalho, Maria Durce C. G.
Silva, Paula F. S. da
Rocha, Maria Angela Wanderley
Ramos, Regina Coeli Ferreira
Brandão-Filho, Sinval Pinto
Cordeiro, Marli Tenorio
Bezerra, Luciana Caroline Albuquerque
Dimech, George
Valongueiro, Sandra
Pires, Pedro
Castanha, Priscila Mayrelle da Silva
Dhalia, Rafael
Marques-Júnior, Ernesto Torres Azevedo
Rodrigues, Laura C.
Miranda-Filho, Demócrito de Barros
Montarroyos, Ulisses Ramos
Martelli, Celina Maria Turchi
Araújo, Thalia Velho Barreto de
Brickley, Elizabeth
Albuquerque, Maria de Fátima Pessoa Militão de
Souza, Wayner Vieira
Ventura, Liana O.
Ventura, Camila V.
Gois, Adriana L.
Leal, Mariana C.
Oliveira, Danielle Maria da Silva
Eickmann, Sophie Helena
Carvalho, Maria Durce C. G.
Silva, Paula F. S. da
Rocha, Maria Angela Wanderley
Ramos, Regina Coeli Ferreira
Brandão-Filho, Sinval Pinto
Cordeiro, Marli Tenorio
Bezerra, Luciana Caroline Albuquerque
Dimech, George
Valongueiro, Sandra
Pires, Pedro
Castanha, Priscila Mayrelle da Silva
Dhalia, Rafael
Marques-Júnior, Ernesto Torres Azevedo
Rodrigues, Laura C.
Affilliation
Universidade Federal de Pernambuco. Departamento de Medicina Tropical. Recife, PE, Brasil / Universidade de Pernambuco. Faculdade de Ciências Médicas. Recife, PE, Brasil.
Universidade de Pernambuco. Faculdade de Ciências Médicas. Recife, PE, Brasil.
Universidade de Pernambuco. Instituto de Ciências Biológicas. Recife, PE, Brasil.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Departamento de Saúde Coletiva. Recife, PE, Brasil.
Universidade Federal de Pernambuco. Departamento de Medicina Social. Recife, PE, Brasil.
London School of Hygiene & Tropical Medicine. Department of Infectious Disease Epidemiology. London, United Kingdom.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Departamento de Saúde Coletiva. Recife, PE, Brasil.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Departamento de Saúde Coletiva. Recife, PE, Brasil.
Fundação Altino Ventura. Departamento de Oftalmologia. Recife, PE, Brasil.
Fundação Altino Ventura. Departamento de Oftalmologia. Recife, PE, Brasil.
Fundação Altino Ventura. Departamento de Oftalmologia. Recife, PE, Brasil.
Universidade Federal de Pernambuco. Departamento de Cirurgia. Recife, PE, Brasil.
Hospital Universitário Oswaldo Cruz. UTI Pediátrica. Recife, PE, Brasil.
Universidade Federal de Pernambuco. Departamento Materno-Infantil. Recife, PE, Brasil.
Hospital Universitário Oswaldo Cruz. Departamento de Neurologia. Recife, PE, Brasil.
Hospital Universitário Oswaldo Cruz. Departamento de Neurologia. Recife, PE, Brasil.
Universidade de Pernambuco. Faculdade de Ciências Médicas. Recife, PE, Brasil.
Hospital Universitário Oswaldo Cruz. Departamento de Infectologia Pediátrica. Recife, PE, Brasil.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Departamento de Imunologia. Recife, PE, Brasil.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Laboratório de Virologia e Terapia Experimental. Recife, PE, Brasil.
Secretaria de Saúde de Pernambuco. Secretaria Executiva da Vigilância em Saúde. Recife, PE, Brasil.
Secretaria de Saúde de Pernambuco. Secretaria Executiva da Vigilância em Saúde. Recife, PE, Brasil.
Universidade Federal de Pernambuco. Departamento de Medicina Social. Recife, PE, Brasil.
Universidade de Pernambuco. Departamento Materno-Infantil. Recife, PE, Brasil.
Universidade de Pernambuco. Programa de Pós-Graduação em Ciências da Saúde. Recife, PE, Brasil.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Laboratório de Virologia e Terapia Experimental. Recife, PE, Brasil.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Laboratório de Virologia e Terapia Experimental. Recife, PE, Brasil.
London School of Hygiene & Tropical Medicine. Department of Infectious Disease Epidemiology. London, United Kingdom.
Universidade de Pernambuco. Faculdade de Ciências Médicas. Recife, PE, Brasil.
Universidade de Pernambuco. Instituto de Ciências Biológicas. Recife, PE, Brasil.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Departamento de Saúde Coletiva. Recife, PE, Brasil.
Universidade Federal de Pernambuco. Departamento de Medicina Social. Recife, PE, Brasil.
London School of Hygiene & Tropical Medicine. Department of Infectious Disease Epidemiology. London, United Kingdom.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Departamento de Saúde Coletiva. Recife, PE, Brasil.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Departamento de Saúde Coletiva. Recife, PE, Brasil.
Fundação Altino Ventura. Departamento de Oftalmologia. Recife, PE, Brasil.
Fundação Altino Ventura. Departamento de Oftalmologia. Recife, PE, Brasil.
Fundação Altino Ventura. Departamento de Oftalmologia. Recife, PE, Brasil.
Universidade Federal de Pernambuco. Departamento de Cirurgia. Recife, PE, Brasil.
Hospital Universitário Oswaldo Cruz. UTI Pediátrica. Recife, PE, Brasil.
Universidade Federal de Pernambuco. Departamento Materno-Infantil. Recife, PE, Brasil.
Hospital Universitário Oswaldo Cruz. Departamento de Neurologia. Recife, PE, Brasil.
Hospital Universitário Oswaldo Cruz. Departamento de Neurologia. Recife, PE, Brasil.
Universidade de Pernambuco. Faculdade de Ciências Médicas. Recife, PE, Brasil.
Hospital Universitário Oswaldo Cruz. Departamento de Infectologia Pediátrica. Recife, PE, Brasil.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Departamento de Imunologia. Recife, PE, Brasil.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Laboratório de Virologia e Terapia Experimental. Recife, PE, Brasil.
Secretaria de Saúde de Pernambuco. Secretaria Executiva da Vigilância em Saúde. Recife, PE, Brasil.
Secretaria de Saúde de Pernambuco. Secretaria Executiva da Vigilância em Saúde. Recife, PE, Brasil.
Universidade Federal de Pernambuco. Departamento de Medicina Social. Recife, PE, Brasil.
Universidade de Pernambuco. Departamento Materno-Infantil. Recife, PE, Brasil.
Universidade de Pernambuco. Programa de Pós-Graduação em Ciências da Saúde. Recife, PE, Brasil.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Laboratório de Virologia e Terapia Experimental. Recife, PE, Brasil.
Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Laboratório de Virologia e Terapia Experimental. Recife, PE, Brasil.
London School of Hygiene & Tropical Medicine. Department of Infectious Disease Epidemiology. London, United Kingdom.
Abstract
Background: While Zika virus (ZIKV) is now widely recognized as a teratogen, the frequency and full spectrum of adverse outcomes of congenital ZIKV infection remains incompletely understood. Methods: Participants in the MERG cohort of pregnant women with rash, recruited from the surveillance system from December/2015-June/2017. Exposure definition was based on a combination of longitudinal data from molecular, serologic (IgM and IgG3) and plaque reduction neutralization tests for ZIKV. Children were evaluated by a team of clinical specialists and by transfontanelle ultrasound and were classified as having microcephaly and/or other signs/symptoms consistent with congenital Zika syndrome (CZS). Risks of adverse outcomes were quantified according to the relative evidence of a ZIKV infection in pregnancy. Findings: 376 women had confirmed and suspected exposure to ZIKV. Among evaluable children born to these mothers, 20% presented with an adverse outcome compatible with exposure to ZIKV during pregnancy. The absolute risk of microcephaly was 2.9% (11/376), of calcifications and/or ventriculomegaly was 7.2% (13/180), of additional neurologic alterations was 5.3% (13/245), of ophthalmologic abnormalities was 7% (15/214), and of dysphagia was 1.8% (4/226). Less than 1% of the children experienced abnormalities across all of the domains simultaneously. Interpretation: Although approximately one-fifth of children with confirmed and suspected exposure to ZIKV in pregnancy presented with at least one abnormality compatible with CZS, the manifestations presented more frequently in isolation than in combination. Due to the rare nature of some outcomes and the possibility of later manifestations, large scale individual participant data meta-analysis and the long-term evaluation of children are imperative to identify the full spectrum of this syndrome and to plan actions to reduce damages.
Keywords
Zika virus (ZIKV)Congenital Zika syndrome (CZS)
ZIKV infection in pregnancy
Pernambuco, Brazil
Publisher
Public Library of Science
Citation
XIMENES, Ricardo Arraes de Alencar et al. Zika-related adverse outcomes in a cohort of pregnant women with rash in Pernambuco, Brazil. PLoS Neglected Tropical Diseases, v. 15, n. 3, p. 1-20, Mar. 2020.DOI
10.1371/journal.pntd.0009216ISSN
1935-2727Notes
On behalf of the Microcephaly Epidemic Research Group (MERG).Author summary: The ability to meaningfully quantify the absolute and relative risks of Congenital Zika Syndrome is contingent on the accurate identification of ZIKV infections in pregnant women and the long-term follow-up of children at risk. This study builds on the evidence base on ZIKV in pregnancy by not only examining pregnancy and birth outcomes, but also considering later onset manifestations of Congenital Zika Syndrome, conducting a deep and standardized investigation of infant outcomes. In addition, it used unprecedented repeated testing and the use of multiple diagnostic platforms, including qRT-PCR, IgM and IgG3 ELISAs, and PRNTs to identify ZIKV cases. The absolute risk of microcephaly was 2.9%, of calcifications and/or ventriculomegaly was 7.2%, of additional neurologic alterations was 5.3%, of ophthalmologic abnormalities was 7% and of dysphagia was 1.8%. The manifestations presented more frequently in isolation than in combination (i.e., less than 1% of the children experienced abnormalities across all of the domains simultaneously). Although approximately one-fifth of children with confirmed and suspected exposure to ZIKV in pregnancy presented with at least one abnormality compatible with CZS, the manifestations presented more frequently in isolation than in combination.
Related items
Showing items related by title, author, creator and subject.
-
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Klionsky, Daniel J. et al. | Date Issued: 2016 -
Recomendações e orientações em saúde mental e atenção psicossocial na COVID-19
Pizzinato, Adolfo et al. | Date Issued: 2020No mesmo ano de celebração de seus 120 anos, a Fundação Oswaldo Cruz vem mobilizando toda a sua experiência, infraestrutura, recursos e conhecimentos para o enfrentamento de uma das maiores crises sanitárias desde a pandemia ... -
Atenção, educação e gestão: produções da Rede PROFSAÚDE vol.3
Lemos, Adriana et al. | Date Issued: 2021O terceiro volume desta obra consolida um primeiro ciclo virtuoso de trabalhos acadêmicos, reflexões e proposições empreendidos por trabalhadores e trabalhadoras do SUS e da comunidade acadêmica de todas as partes do país ...
Share